Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues

Kathryn Cunningham, Robert G. Fox, Noelle Anastasio, Marcy J. Bubar, Sonja J. Stutz, F. Gerard Moeller, Scott R. Gilbertson, Sharon Rosenzweig-Lipson

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Serotonin (5-HT) controls affective and motivational aspects of palatable food and drug reward and the 5-HT2C receptor (5-HT2CR) has emerged as a key regulator in this regard. We have evaluated the efficacy of a selective 5-HT2CR agonist, WAY 163909, in cocaine and sucrose self-administration and reinstatement assays employing parallel experimental designs in free-fed rats. WAY 163909 dose-dependently reduced the reinforcing efficacy of cocaine (ID50 = 1.19 mg/kg) and sucrose (ID50 = 0.7 mg/kg) as well as reinstatement (ID50 = 0.5 mg/kg) elicited by exposure to cocaine-associated contextual cues, but not sucrose-associated contextual cues. The ID50 of WAY 163909 predicted to decrease the reinforcing efficacy of cocaine or sucrose as well as reinstatement upon exposure to cocaine-associated cues was ∼5-12-fold lower than that predicted to suppress horizontal ambulation (ID50 = 5.89 mg/kg) and ∼2-5-fold lower than that predicted to suppress vertical activity (ID 50 = 2.3 mg/kg). Thus, selective stimulation of the 5-HT 2CR decreases the reinforcing efficacy of cocaine and sucrose in freely-fed rats, but differentially alters the incentive-salience value of cocaine- vs. sucrose-associated cues at doses that do not impair locomotor activity. Future research is needed to tease apart the precise contribution of 5-HT2CR neurocircuitry in reward and motivation and the learning and memory processes that carry the encoding for associations between environmental cues and consumption of rewarding stimuli. A more complete preclinical evaluation of these questions will ultimately allow educated proof-of-concept trials to test the efficacy of selective 5-HT2CR agonists as adjunctive therapy in chronic health maladies including obesity, eating disorders and drug addiction.

Original languageEnglish (US)
Pages (from-to)513-523
Number of pages11
JournalNeuropharmacology
Volume61
Issue number3
DOIs
StatePublished - Sep 2011

Fingerprint

Receptor, Serotonin, 5-HT2C
Cocaine
Cues
Sucrose
Motivation
Serotonin 5-HT2 Receptor Agonists
Serotonin
Reward
Self Administration
Locomotion
Walking
Substance-Related Disorders
Research Design
Obesity
Learning
Food
Health

Keywords

  • 5-HT receptor
  • Addiction
  • Cocaine
  • Reward
  • Self-administration
  • Serotonin
  • Sucrose
  • WAY 163909

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues. / Cunningham, Kathryn; Fox, Robert G.; Anastasio, Noelle; Bubar, Marcy J.; Stutz, Sonja J.; Moeller, F. Gerard; Gilbertson, Scott R.; Rosenzweig-Lipson, Sharon.

In: Neuropharmacology, Vol. 61, No. 3, 09.2011, p. 513-523.

Research output: Contribution to journalArticle

Cunningham, Kathryn ; Fox, Robert G. ; Anastasio, Noelle ; Bubar, Marcy J. ; Stutz, Sonja J. ; Moeller, F. Gerard ; Gilbertson, Scott R. ; Rosenzweig-Lipson, Sharon. / Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues. In: Neuropharmacology. 2011 ; Vol. 61, No. 3. pp. 513-523.
@article{b33b0e8f9bc141f89437d42bffc10883,
title = "Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues",
abstract = "Serotonin (5-HT) controls affective and motivational aspects of palatable food and drug reward and the 5-HT2C receptor (5-HT2CR) has emerged as a key regulator in this regard. We have evaluated the efficacy of a selective 5-HT2CR agonist, WAY 163909, in cocaine and sucrose self-administration and reinstatement assays employing parallel experimental designs in free-fed rats. WAY 163909 dose-dependently reduced the reinforcing efficacy of cocaine (ID50 = 1.19 mg/kg) and sucrose (ID50 = 0.7 mg/kg) as well as reinstatement (ID50 = 0.5 mg/kg) elicited by exposure to cocaine-associated contextual cues, but not sucrose-associated contextual cues. The ID50 of WAY 163909 predicted to decrease the reinforcing efficacy of cocaine or sucrose as well as reinstatement upon exposure to cocaine-associated cues was ∼5-12-fold lower than that predicted to suppress horizontal ambulation (ID50 = 5.89 mg/kg) and ∼2-5-fold lower than that predicted to suppress vertical activity (ID 50 = 2.3 mg/kg). Thus, selective stimulation of the 5-HT 2CR decreases the reinforcing efficacy of cocaine and sucrose in freely-fed rats, but differentially alters the incentive-salience value of cocaine- vs. sucrose-associated cues at doses that do not impair locomotor activity. Future research is needed to tease apart the precise contribution of 5-HT2CR neurocircuitry in reward and motivation and the learning and memory processes that carry the encoding for associations between environmental cues and consumption of rewarding stimuli. A more complete preclinical evaluation of these questions will ultimately allow educated proof-of-concept trials to test the efficacy of selective 5-HT2CR agonists as adjunctive therapy in chronic health maladies including obesity, eating disorders and drug addiction.",
keywords = "5-HT receptor, Addiction, Cocaine, Reward, Self-administration, Serotonin, Sucrose, WAY 163909",
author = "Kathryn Cunningham and Fox, {Robert G.} and Noelle Anastasio and Bubar, {Marcy J.} and Stutz, {Sonja J.} and Moeller, {F. Gerard} and Gilbertson, {Scott R.} and Sharon Rosenzweig-Lipson",
year = "2011",
month = "9",
doi = "10.1016/j.neuropharm.2011.04.034",
language = "English (US)",
volume = "61",
pages = "513--523",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Selective serotonin 5-HT2C receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues

AU - Cunningham, Kathryn

AU - Fox, Robert G.

AU - Anastasio, Noelle

AU - Bubar, Marcy J.

AU - Stutz, Sonja J.

AU - Moeller, F. Gerard

AU - Gilbertson, Scott R.

AU - Rosenzweig-Lipson, Sharon

PY - 2011/9

Y1 - 2011/9

N2 - Serotonin (5-HT) controls affective and motivational aspects of palatable food and drug reward and the 5-HT2C receptor (5-HT2CR) has emerged as a key regulator in this regard. We have evaluated the efficacy of a selective 5-HT2CR agonist, WAY 163909, in cocaine and sucrose self-administration and reinstatement assays employing parallel experimental designs in free-fed rats. WAY 163909 dose-dependently reduced the reinforcing efficacy of cocaine (ID50 = 1.19 mg/kg) and sucrose (ID50 = 0.7 mg/kg) as well as reinstatement (ID50 = 0.5 mg/kg) elicited by exposure to cocaine-associated contextual cues, but not sucrose-associated contextual cues. The ID50 of WAY 163909 predicted to decrease the reinforcing efficacy of cocaine or sucrose as well as reinstatement upon exposure to cocaine-associated cues was ∼5-12-fold lower than that predicted to suppress horizontal ambulation (ID50 = 5.89 mg/kg) and ∼2-5-fold lower than that predicted to suppress vertical activity (ID 50 = 2.3 mg/kg). Thus, selective stimulation of the 5-HT 2CR decreases the reinforcing efficacy of cocaine and sucrose in freely-fed rats, but differentially alters the incentive-salience value of cocaine- vs. sucrose-associated cues at doses that do not impair locomotor activity. Future research is needed to tease apart the precise contribution of 5-HT2CR neurocircuitry in reward and motivation and the learning and memory processes that carry the encoding for associations between environmental cues and consumption of rewarding stimuli. A more complete preclinical evaluation of these questions will ultimately allow educated proof-of-concept trials to test the efficacy of selective 5-HT2CR agonists as adjunctive therapy in chronic health maladies including obesity, eating disorders and drug addiction.

AB - Serotonin (5-HT) controls affective and motivational aspects of palatable food and drug reward and the 5-HT2C receptor (5-HT2CR) has emerged as a key regulator in this regard. We have evaluated the efficacy of a selective 5-HT2CR agonist, WAY 163909, in cocaine and sucrose self-administration and reinstatement assays employing parallel experimental designs in free-fed rats. WAY 163909 dose-dependently reduced the reinforcing efficacy of cocaine (ID50 = 1.19 mg/kg) and sucrose (ID50 = 0.7 mg/kg) as well as reinstatement (ID50 = 0.5 mg/kg) elicited by exposure to cocaine-associated contextual cues, but not sucrose-associated contextual cues. The ID50 of WAY 163909 predicted to decrease the reinforcing efficacy of cocaine or sucrose as well as reinstatement upon exposure to cocaine-associated cues was ∼5-12-fold lower than that predicted to suppress horizontal ambulation (ID50 = 5.89 mg/kg) and ∼2-5-fold lower than that predicted to suppress vertical activity (ID 50 = 2.3 mg/kg). Thus, selective stimulation of the 5-HT 2CR decreases the reinforcing efficacy of cocaine and sucrose in freely-fed rats, but differentially alters the incentive-salience value of cocaine- vs. sucrose-associated cues at doses that do not impair locomotor activity. Future research is needed to tease apart the precise contribution of 5-HT2CR neurocircuitry in reward and motivation and the learning and memory processes that carry the encoding for associations between environmental cues and consumption of rewarding stimuli. A more complete preclinical evaluation of these questions will ultimately allow educated proof-of-concept trials to test the efficacy of selective 5-HT2CR agonists as adjunctive therapy in chronic health maladies including obesity, eating disorders and drug addiction.

KW - 5-HT receptor

KW - Addiction

KW - Cocaine

KW - Reward

KW - Self-administration

KW - Serotonin

KW - Sucrose

KW - WAY 163909

UR - http://www.scopus.com/inward/record.url?scp=80955177188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80955177188&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2011.04.034

DO - 10.1016/j.neuropharm.2011.04.034

M3 - Article

VL - 61

SP - 513

EP - 523

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 3

ER -